SYON CAPITAL LLC

Position in ABBV — AbbVie Inc.

CIK 1999353 SAN FRANCISCO, CA

Position in ABBV

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$5,619,506

-$302,269 QoQ

Shares Held

25,838

-0.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.44%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SYON CAPITAL LLC holds $41,641,759 across 15 Drug Manufacturers - General names. ABBV ranks #3 (13.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	12,819	$11,790,531
2	JNJ	Johnson & Johnson	29,338	$7,171,380
3	ABBV	AbbVie Inc. This page	25,838	$5,619,506
4	MRK	Merck & Co., Inc.	25,670	$3,087,844
5	AMGN	Amgen Inc	8,271	$2,910,151
6	GILD	Gilead Sciences, Inc.	20,745	$2,891,230
7	AZN	Astrazeneca PLC	11,958	$2,358,356
8	GSK	GSK plc	29,471	$1,626,504

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,619,506	25,838	-0.3%	Shares	Sole	2026-05-13
2025-12-31	$5,921,775	25,917	+4.3%	Shares	Sole	2026-02-11
2025-09-30	$5,751,222	24,839	+16.4%	Shares	Sole	2025-11-07
2025-06-30	$3,962,615	21,348	-6.1%	Shares	Sole	2025-08-14
2025-03-31	$4,761,342	22,725	+8.0%	Shares	Sole	2025-05-15
2024-12-31	$3,739,696	21,045	+19.1%	Shares	Sole	2025-02-14
2024-09-30	$3,490,261	17,674	+2.8%	Shares	Sole	2024-11-13
2024-06-30	$2,950,144	17,200	-4.2%	Shares	Sole	2024-08-13
2024-03-31	$3,268,512	17,949	+9.9%	Shares	Sole	2024-05-14
2023-12-31	$2,531,279	16,334	+43.6%	Shares	Sole	2024-02-26
2023-09-30	$1,695,110	11,372	—	Shares	Sole	2023-11-03
No filing history on record for this holder in this stock.